KAM
GCVRZ

Kazazian Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Kazazian Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-49,328
Closed -$6K – 71
2015
Q4 		$6K Sell
49,328
-6,352
-11% -$897 0.01% 51
2015
Q3 		$11K Buy
55,680
+3,778
+7% +$1.28K 0.01% 88
2015
Q2 		$36K Sell
51,902
-4,892
-9% -$3.38K 0.04% 74
2015
Q1 		$39K Sell
56,794
-33,619
-37% -$23.5K 0.05% 79
2014
Q4 		$71K Buy
+90,413
New +$61.8K 0.06% 77

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Kazazian Asset Management's GCVRZ Position: Q1 2016 in Review

Kazazian Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2016, closing a stake of 49,328 shares — an estimated $6K sold.

Kazazian Asset Management first reported a position in GCVRZ in Q4 2014 and held it in 5 quarters. The position peaked at $71K in Q4 2014. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2016.

  • Kazazian Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2016 after selling out during the quarter.
  • Kazazian Asset Management sold 49,328 Sanofi Contingent Value Rights shares in Q1 2016, an estimated $6K.
  • Kazazian Asset Management first reported a position in Sanofi Contingent Value Rights in Q4 2014 and held it in 5 quarters.
  • Kazazian Asset Management's Sanofi Contingent Value Rights position peaked at $71K in Q4 2014.
  • 106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2016.

Based on Kazazian Asset Management's 13F filing for Q1 2016, filed 16 May 2016.